234 related articles for article (PubMed ID: 36528040)
1. The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline.
Frost I; Sati H; Garcia-Vello P; Hasso-Agopsowicz M; Lienhardt C; Gigante V; Beyer P
Lancet Microbe; 2023 Feb; 4(2):e113-e125. PubMed ID: 36528040
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance.
Del Bino L; Østerlid KE; Wu DY; Nonne F; Romano MR; Codée J; Adamo R
Chem Rev; 2022 Oct; 122(20):15672-15716. PubMed ID: 35608633
[TBL] [Abstract][Full Text] [Related]
3. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E; Carrara E; Savoldi A; Harbarth S; Mendelson M; Monnet DL; Pulcini C; Kahlmeter G; Kluytmans J; Carmeli Y; Ouellette M; Outterson K; Patel J; Cavaleri M; Cox EM; Houchens CR; Grayson ML; Hansen P; Singh N; Theuretzbacher U; Magrini N;
Lancet Infect Dis; 2018 Mar; 18(3):318-327. PubMed ID: 29276051
[TBL] [Abstract][Full Text] [Related]
4. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
[TBL] [Abstract][Full Text] [Related]
5. The current state of immunization against Gram-negative bacteria in children: a review of the literature.
Broad J; Le Doare K; Heath PT; Hallchurch P; Whelan I; Boyd H; Carruthers E; Sharland M; Ladhani S
Curr Opin Infect Dis; 2020 Dec; 33(6):517-529. PubMed ID: 33044242
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.
O'Ryan M; Vidal R; del Canto F; Carlos Salazar J; Montero D
Hum Vaccin Immunother; 2015; 11(3):601-19. PubMed ID: 25715096
[TBL] [Abstract][Full Text] [Related]
7. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Use of Molecular Methods for the Diagnosis of Bacterial Infections.
Gerace E; Mancuso G; Midiri A; Poidomani S; Zummo S; Biondo C
Pathogens; 2022 Jun; 11(6):. PubMed ID: 35745518
[TBL] [Abstract][Full Text] [Related]
9. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
[TBL] [Abstract][Full Text] [Related]
10. Glycoconjugate vaccines against antimicrobial resistant pathogens.
Sorieul C; Dolce M; Romano MR; Codée J; Adamo R
Expert Rev Vaccines; 2023; 22(1):1055-1078. PubMed ID: 37902243
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
[TBL] [Abstract][Full Text] [Related]
12. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
13. Novel antimicrobial agents for combating antibiotic-resistant bacteria.
Chang RYK; Nang SC; Chan HK; Li J
Adv Drug Deliv Rev; 2022 Aug; 187():114378. PubMed ID: 35671882
[TBL] [Abstract][Full Text] [Related]
14. Distribution and Drug Resistance of Bacterial Pathogens Associated with Lower Respiratory Tract Infection in Children and the Effect of COVID-19 on the Distribution of Pathogens.
Zhu X; Ye T; Zhong H; Luo Y; Xu J; Zhang Q; Luo X; Wang Q; Zhang L; Song P; Zhang J
Can J Infect Dis Med Microbiol; 2022; 2022():1181283. PubMed ID: 35368516
[TBL] [Abstract][Full Text] [Related]
15. [Pathogens' distribution and changes of antimicrobial resistance in the bile of acute biliary tract infection patients].
Wu ZY; Wu XS; Yao WY; Wang XF; Quan ZW; Gong W
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):24-31. PubMed ID: 33412630
[No Abstract] [Full Text] [Related]
16. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
Seifert H; Blondeau J; Dowzicky MJ
Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance of Escherichia coli, Enterobacter spp., Klebsiella pneumoniae and Enterococcus spp. isolated from the feces of giant panda.
Wang X; Zhang Y; Li C; Li G; Wu D; Li T; Qu Y; Deng W; He Y; Penttinen P; Zhang H; Huang Y; Zhao K; Zou L
BMC Microbiol; 2022 Apr; 22(1):102. PubMed ID: 35421931
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
19. The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance.
Lopes BS; Hanafiah A; Nachimuthu R; Muthupandian S; Md Nesran ZN; Patil S
Molecules; 2022 May; 27(9):. PubMed ID: 35566343
[TBL] [Abstract][Full Text] [Related]
20. Potential targets for next generation antimicrobial glycoconjugate vaccines.
Micoli F; Costantino P; Adamo R
FEMS Microbiol Rev; 2018 May; 42(3):388-423. PubMed ID: 29547971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
